Cell and Molecular Therapeutics Laboratory, Department of Biochemistry and Biotechnology, Oriental Institute of Science and Technology, Midnapore, India.
Agricure Biotech Research Society, Epidemiology and Human Health Division, Midnapore, India.
Drug Dev Res. 2021 Feb;82(1):86-96. doi: 10.1002/ddr.21730. Epub 2020 Aug 7.
SARS-CoV-2 or COVID-19 pandemic global outbreak created the most unstable situation of human health-economy. In the past two decades different parts of the word experienced smaller or bigger outbreak related to human coronaviruses. The spike glycoproteins of the COVID-19 (similar to SARS-CoV) attach to the angiotensin-converting enzyme (ACE2) and transit over a stabilized open state for the viral internalization to the host cells and propagate with great efficacy. Higher rate of mutability makes this virus unpredictable/less sensitive to the protein/nucleic acid based drugs. In this emergent situation, drug-induced destabilization of spike binding to RBD could be a good strategy. In the current study we demonstrated by bioinformatics (CASTp: computed atlas of surface topography of protein, PyMol: molecular visualization) and molecular docking (PatchDock and Autodock) experiments that tea flavonoids catechin products mainly epigallocatechin gallate or other like theaflavin gallate demonstrated higher atomic contact energy (ACE) value, binding energy, Ki value, ligand efficiency, surface area and more amino acid interactions than hydroxychloroquine (HCQ) during binding in the central channel of the spike protein. Moreover, out of three distinct binding sites (I, II and III) of spike core when HCQ binds only with site III (farthest from the nCoV-RBD of ACE2 contact), epigallocatechin gallate and theaflavin gallate bind all three sites. As sites I and II are in closer contact with open state location and viral-host contact area, these drugs might have significant effects. Taking into account the toxicity/side effects by chloroquine/HCQ, present drugs may be important. Our laboratory is working on tea flavonoids and other phytochemicals in the protection from toxicity, DNA/mitochondrial damage, inflammation and so on. The present data might be helpful for further analysis of flavonoids in this emergent pandemic situation.
SARS-CoV-2 或 COVID-19 大流行的全球爆发给人类健康和经济带来了最不稳定的局面。在过去的二十年中,世界不同地区都经历了较小或较大规模的与人类冠状病毒相关的爆发。COVID-19(与 SARS-CoV 相似)的刺突糖蛋白附着在血管紧张素转换酶(ACE2)上,并在稳定的开放状态下转位,使病毒进入宿主细胞并高效繁殖。更高的突变率使这种病毒难以预测/对基于蛋白质/核酸的药物不太敏感。在这种紧急情况下,药物诱导的刺突结合 RBD 的不稳定性可能是一种很好的策略。在目前的研究中,我们通过生物信息学(CASTp:蛋白质表面形貌计算图集、PyMol:分子可视化)和分子对接(PatchDock 和 Autodock)实验表明,茶类黄酮儿茶素产品主要是表没食子儿茶素没食子酸酯或其他类似的茶黄素没食子酸酯,在与 spike 蛋白中央通道结合时,表现出更高的原子接触能(ACE)值、结合能、Ki 值、配体效率、表面积和更多的氨基酸相互作用,比羟氯喹(HCQ)高。此外,在 spike 核心的三个不同结合位点(I、II 和 III)中,当 HCQ 仅与 III 位点结合时(距离 ACE2 与 nCoV-RBD 的接触最远),表没食子儿茶素没食子酸酯和茶黄素没食子酸酯结合了所有三个位点。由于位点 I 和 II 与开放状态位置和病毒-宿主接触区域更接近,这些药物可能会产生显著的效果。考虑到氯喹/HCQ 的毒性/副作用,目前的药物可能很重要。我们的实验室正在研究茶类黄酮和其他植物化学物质在防止毒性、DNA/线粒体损伤、炎症等方面的作用。目前的数据可能有助于进一步分析这种紧急大流行情况下的类黄酮。